BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21412967)

  • 1. Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
    Renard M; Suciu S; Bertrand Y; Uyttebroeck A; Ferster A; van der Werff Ten Bosch J; Mazingue F; Plouvier E; Robert A; Boutard P; Millot F; Munzer M; Mechinaud F; Lescoeur B; Baila L; Vandecruys E; Benoit Y; Philippet P;
    Pediatr Blood Cancer; 2011 Jul; 57(1):119-25. PubMed ID: 21412967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?].
    García Zueco JC; Torres Gómez M; López Gómez L; Martín Guerrero Y
    Sangre (Barc); 1992 Apr; 37(2):152-3. PubMed ID: 1621188
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.
    Felice MS; Rossi JG; Gallego MS; Alfaro EM; Zubizarreta PA; Fraquelli LE; Alonso CN; Guitter MR; Scopinaro MJ
    Pediatr Blood Cancer; 2011 Jul; 57(1):47-55. PubMed ID: 21394895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
    Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
    Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
    J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
    Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
    Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
    Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
    Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Kudva GC; Chandy M; Dennison D; Srivastava A; Bhushan V
    Indian J Cancer; 1994 Mar; 31(1):1-7. PubMed ID: 8063329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The fate of children after discontinuation of treatment for acute lymphoblastic leukemia].
    Derulska D; Rokicka-Milewska R; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Darmal B; Jakowicka M
    Acta Haematol Pol; 1991; 22(2):223-32. PubMed ID: 1841493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
    Sandoval C; Jayabose S
    Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.